SCHEMBL606935

SCHEMBL606935

OC(CN1CCN(Cc2ccco2)CC1)Cn1c2ccccc2c2cc(Br)ccc21

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.68
MEN1 O00255 3/20 0.68
RAD52 P43351 2/20 0.68
MAPT P10636 6/20 0.59
HTT P42858 4/20 0.59
NPSR1 Q6W5P4 2/20 0.59
BAX Q07812 1/20 0.56
LMNA P02545 5/20 0.56
GAA P10253 1/20 0.56
MAPK1 P28482 5/20 0.55
TP53 P04637 2/20 0.55
ALOX15 P16050 2/20 0.55
CYP3A4 P08684 1/20 0.55
TSHR P16473 1/20 0.55
ATM Q13315 1/20 0.52
POLB P06746 2/20 0.51
HSD17B10 Q99714 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
DNM1 Q05193 1/20 0.46
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5087776 0.88 KMT2A (0.68) KMT2AMEN1RAD52MAPTHTT
SCHEMBL6815606 0.87 MEN1 (0.88) KMT2AMEN1RAD52MAPTBAX
SCHEMBL607753 0.85 KMT2A (0.67) KMT2AMEN1RAD52MAPTHTT
SCHEMBL1305296 0.82 MEN1 (0.78) KMT2AMEN1RAD52MAPTHTT
SCHEMBL7651313 0.81 KMT2A (0.44) KMT2AMEN1RAD52MAPTHTT
SCHEMBL610230 0.81 MEN1 (0.73) KMT2AMEN1RAD52MAPTBAX
SCHEMBL6819686 0.81 BAX (0.82) KMT2AMEN1RAD52MAPTHTT
SCHEMBL607210 0.80 MEN1 (0.69) KMT2AMEN1RAD52MAPTHTT
SCHEMBL607057 0.80 MEN1 (0.69) KMT2AMEN1RAD52MAPTHTT
SCHEMBL607402 0.80 RAD52 (0.69) KMT2AMEN1RAD52MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1237887-B1 9-(PIPERAZINYLALKYL)CARBAZOLES AS BAX-MODULATORS SERONO LAB (CH) 2008-06-04 EP claimed
EP-1237887-A1 9-(PIPERAZINYLALKYL)CARBAZOLES AS BAX-MODULATORS Applied Research Systems ARS Holding N.V. (AN) 2002-09-11 EP claimed
WO-2001029028-A1 9- (PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-04-26 WO claimed
US-8410110-B2 9-(piperazinylalkyl) carbazoles as Bax-modulators MERCK SERONO SA (CH) 2013-04-02 US disclosed
US-20120040933-A1 9-(PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2012-02-16 US disclosed
US-8053436-B1 9-(piperazinylalkyl) carbazoles as bax-modulators MERCK SERONO SA (CH) 2011-11-08 US disclosed
EP-1237887-B1 9-(PIPERAZINYLALKYL)CARBAZOLES AS BAX-MODULATORS SERONO LAB (CH) 2008-06-04 EP disclosed
EP-1237887-A1 9-(PIPERAZINYLALKYL)CARBAZOLES AS BAX-MODULATORS Applied Research Systems ARS Holding N.V. (AN) 2002-09-11 EP disclosed
WO-2001029028-A1 9- (PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040933-A1 9-(PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS BCL2, BAX, BAD KMT2A 732/4885MEN1 3810/4885RAD52 3656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.